Report of Three Cases of AKI Following Weight-Based Gentamicin Prophylaxis for IPP Implantation: Potential Concerns for Patients with Preexisting Conditions

Table 1

Patient characteristics.

Patient	Age (years)	Comorbidities	Gentamicin Dose (mg/kg)	Vancomycin Dose (mg/kg)	Pre-op Serum; Cr [eGFR]	Post-op Peak Serum Cr [eGFR]	Follow-up Serum Cr [eGFR]
Case 1	64	HTN, DM-2, CKD, HLD	2.46	8.96	1.41 [65.08]	3.04 [26.82]	1.68 [53.17]
Case 2	65	HTN, DM-2	3.73	8.73	1.02 [94.27]	7.11 [10.03]	1.22 [76.43]
Case 3	65	Obesity, HTN, CKD, DM-2	3.07	17.12	1.55 [58.16]	2.09 [41.19]	1.54 [58.42]

AKI = acute kidney injury, HTN = hypertension, DM-2 = diabetes mellitus type-2, CKD = chronic kidney disease, HLD = hyperlipidemia, IPP = inflatable penile prosthesis, Cr = creatinine (in mg/dL), and eGFR = estimated glomerular filtration rate (in mL/min/1.73 m²).